| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.011 | 1 |